Contents:
She also led the commercial development of new regenerative medicine efforts which focused on cell and tissue therapies in the cardiac, orthopedic and vascular areas. Other corporate positions in Baxter included the spearheading and execution of innovation efforts which led to the creation of a global innovation council, corporate incubator group and implementation of innovation processes globally to drive growth for the corporation.
Before joining Baxter, she worked for H. Heinz in business development and prior to that for Technomic Consultants a specialist in the foodservice industry. In his position, Dr.
Beliveau oversees a number of important angiogenesis-based research projects involving the regulation of VEGF-dependent signaling pathways, contribution of bone marrow-derived cells in tumor angiogenesis, and the identification of new molecular targets and biomarkers, among others.
A particular area of interest and expertise of Dr. Beliveau is in the discovery and application of natural antiangiogenic and antitumor substances found in the diet for cancer prevention and treatment. This burgeoning area of research includes natural angiogenesis inhibitors found in green tea, cruciferous vegetables, soy, berries, and curcumin. He has authored more than papers in peer-reviewed medical journals. Molecular and cellular biologist with expertise in cancer research and tumor angiogenesis.
Almog received a Ph. Almog did her post-doctoral training in the laboratory of Dr. Almog served as an Associate Program Officer, Oncology, at the Adelson Medical Foundation, where she managed global and multi-institutional translational research programs. In addition to her expertise in tumor biology and a broad network of connections with leading scientists and clinicians in cancer research and clinical oncology, Dr. Almog has extensive hands-on experience with a variety of techniques ranging from the molecular level DNA, RNA and proteins to tissue, organ and mouse models in cancer biology, as well as extensive experience in project management and program coordination.
Almog is the author of numerous scientific publications in high impact journals as well as oral and poster presentations at international conferences. With over scientific publications in peer-reviewed journals and an H index of 78, Dr. Albini is one of the most consulted scientists in the world.
Albini has spent most of her scientific and academic career in experimental and translational oncology. Her main fields of interest are angiogenesis, anti-angiogeneic gene therapy, chemoprevention, immunopathogenesis, invasion and metastasis, nanoparticles, nanotoxicology, the tumour microenvironment, and vascular biology. She developed new synthetic molecules and flavonoid derivatives for cancer prevention, and invented the most widely used in vitro invasion assay, a publication with over 1, citations. As a champion for women in the field of science, Dr. Albini has fostered the careers of other female investigators, contributed to WICR activities, and published for the Veronesi Foundation.
A true polymath, Dr. Albini has also won the silver medal at the European Veteran Fencing championship, and has written and published six mystery novels under a pen name. William W. Will trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical development for 30 years. As President, Will has testified and presented before congressional and other government panels on the impact of angiogenesis in healthcare, and lectures around the world on angiogenesis-related topics in front of clinical, government, and industrial audiences.
Will received his A. He completed his internship, residency, and fellowship training in General Internal Medicine at the Massachusetts General Hospital in Boston.
He serves as advisor and consultant to leading global public and private companies. He will forever hold an enduring place in the history of cinema, through his portrayal of James Bond from , the longest serving actor in the role of Special Agent Sir Roger made his Bond debut in in Live and Let Die and continued for a total of seven productions.
Notable roles include his work in the television series Ivanhoe , The Alaskans , and Maverick. His breakout role was as Simon Templar in the most successful television series of its time, The Saint. Sir Roger was an internationally celebrated humanitarian. Sir Roger was dedicated to using his influence to spur positive change in the world and was also an ardent activist for cancer research and animal rights.
She is now a full-time artist and SciArt education advocate who believes that sharing the perspective she was blessed to experience through spaceflight has the power to increase our appreciation of and obligation to care for our home planet and each other.
As Acting Chief Strategy Officer of the Angiogenesis Foundation, Eric Lowitt works with the executive team to ignite paradigm-shifting innovations in health promotion and disease prevention to improve health outcomes for people around the world. Over the course of his career, Eric has advised Fortune CEOs, senior public officials, and leaders of nongovernmental organizations in health, strategy, collaboration, and sustainability.
He is fluent in Japanese, a baseball historian, and car enthusiast. Diana develops innovative strategies for advancing health initiatives surrounding the prevention of non-communicable diseases, such as cancer, vision loss, and chronic wounds. Diana is an expert in communicating complex scientific concepts related to science, medicine, and industry. Diana received her undergraduate degree with honors in Biochemical Sciences from Harvard College, and began working with Pixar animators to illustrate molecular phenomena while pursuing a Ph.
As an expert on gynecologic cancers and their treatment, Dr. Viswanathan has published more than articles and chapters, with her primary clinical and research interests focused on gynecologic malignancies, uterine cancers and image-guided brachytherapy. Jairam Vanamala, Ph.
As a recognized leader in the field of functional foods, he received several research projects funded by the United States Department of Agriculture USDA to study the health benefits of whole foods, particularly after processing. George W. Thorn was an electric figure in medicine. Frequently mistaken for a medical student or resident, he remained youthful in outlook and appearance until his 90s. He died on 26 June at the age of George made vital contributions to the clinical use of adrenal steroids.
He began his career in endocrinology as a medical student at the University of Buffalo, went on to Ohio State and then joined the faculty at Johns Hopkins where Harvard found him. The Brigham, as it was called, was then a Dickensian institution as were all of the Harvard hospitals of the mid 20th century. Built in , its design was inspired by a fear of hospital borne infection. The four 30 bed male and female surgical and medical services were wide open, poorly ventilated and over-heated pavilions separated from each other by a long corridor that was still partially open to the elements well into the s.
Flimsy curtains separated the ancient beds.
Privacy was non-existent. So called semi private beds were on a floor above. They were located on open wards as well, but those patients were the private patients of staff members, while the large first-floor pavilions were the provinces of the house staff. A three floor private service was housed near the pillared entrance of the hospital.
It was scarcely lucullan in its appointments, but there the tired interns could make a decent breakfast for themselves on Sunday mornings.
The principle of the grid-overlay technique is based on a virtual grid placed onto the image thereby allowing to measure the number crossing vessels per area. Aho R, Ekfors T, Haltia M, Kalimo H: Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme. Pegylation has also been used on camptothecin and doxorubicin, improving their solubility, circulation time and lowering their toxicity [ 96 , 97 ]. The factors affecting the formation of sporadic CCMs remain unclear. Ofek et al. Dan Rutz, M.
Laboratories at the old Brigham were primitive by any standards. A horribly ventilated and totally inadequate animal facility was in the basement.
Despite lack of space and money, George conjured up a full time staff of investigators. His own program in endocrinology produced George Cahill and Albert Renold among many others.
His many contributions to the endocrinology literature included over papers. To expand the academic department of medicine he focused first on cardiology. He was wise enough to build on the clinical greatness of Samuel A.
Nat Rev Neurosci. Aug;8(8) Angiogenesis in brain tumours. Jain RK(1), di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. More than 70 clinical trials using about 20 anticancer agents that may inhibit angiogenesis in brain tumors are.
Levine and added the cardiac catheterization skills of Lewis Dexter and, later, Dick Gorlin. He attracted house staff of the quality of Don Thomas and Clem Finch and scores of others who became leaders of academic medicine. His discussions of patients on rounds were always brilliant if occasionally somewhat off base. Armed with that creative style, Thorn dissuaded John Merrill from a career in cardiology to lead an effort in renal dialysis and transplant.
The renal transplant program at the Brigham became world-renowned. But his free flowing thought processes and his youthful, friendly personality were sometimes confusing. One inadequate resident once boasted that George had appointed him to the Chief Residency when actually George had fired him! In his later years as the Chief of Medicine, George began to worry about how to elevate the role of basic science in a department of medicine and how to prevent specialists from forgetting general medicine.